Kiminori Kimura, Md

This small study tested a drug called foscenvivint in 5 adults with liver cirrhosis (scarring) caused by HIV and hepatitis C co-infection, who also have hemophilia. The goal was to see if the drug could improve liver function over 24 weeks. The study is complete, but results are …